10-hydroxy-2-decenoic acid has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, S; Fukamachi, K; Iinuma, M; Matsumoto, H; Suzui, M; Yoshimoto, E | 1 |
1 other study(ies) available for 10-hydroxy-2-decenoic acid and Carcinoma
| Article | Year |
|---|---|
Palmitoyl piperidinopiperidine, a novel derivative of 10‑hydroxy‑2‑decenoic acid, as a potent and selective anticancer agent against human colon carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Fatty Acids, Monounsaturated; Female; Humans; Inhibitory Concentration 50; Male; Mice; Molecular Docking Simulation; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |